Literature DB >> 1848712

Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.

M J Picker1, S S Negus, K R Powell.   

Abstract

If different populations of opioid receptors mediate the actions of mu and kappa opioid agonists, then tolerance induced by the chronic administration of a mu agonist should confer cross-tolerance to other mu agonists but not necessarily to those compounds whose effects are mediated by the kappa receptor. This hypothesis was evaluated in the present investigation by examining the effects of the mu agonists morphine, l-methadone and fentanyl, the kappa agonists U50,488 and bremazocine, and the mixed kappa/mu agonist ethylketocyclazocine in rats responding under a fixed-ratio 30 schedule of food presentation before, during and after exposure to a regimen of chronic morphine administration. For comparison, naloxone was evaluated as a representative mu antagonist and the phenothiazine chlorpromazine as a control drug. During all phases of the experiment, each of these compounds produced dose-related decreases in rate of responding. During the daily administration of 40 mg/kg morphine, tolerance developed to the rate-decreasing effects of morphine, l-methadone and fentanyl, and an enhanced sensitivity to the effects of naloxone. In contrast to the effects obtained with these mu opioids, there was no evidence that chronic morphine administration produced tolerance or enhanced sensitivity to the rate-decreasing effects of U50,488, bremazocine, ethylketocyclazocine and chlorpromazine. The present findings demonstrate that the chronic administration of morphine results in the selective development of tolerance to other mu agonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848712     DOI: 10.1007/bf02244087

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

2.  Tolerance and cross-tolerance studies with morphine and ethylketocyclazocine.

Authors:  F Porreca; A Cowan; R B Raffa; R J Tallarida
Journal:  J Pharm Pharmacol       Date:  1982-10       Impact factor: 3.765

3.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

4.  Are there subtypes (isoreceptors) of multiple opiate receptors in the mouse vas deferens?

Authors:  R Schulz; M Wüster
Journal:  Eur J Pharmacol       Date:  1981-11-19       Impact factor: 4.432

5.  Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.

Authors:  G T Shearman; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

6.  Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.

Authors:  R A Harris
Journal:  J Pharmacol Exp Ther       Date:  1980-06       Impact factor: 4.030

7.  Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats.

Authors:  M Picker; J W Heise; L A Dykstra
Journal:  Pharmacol Biochem Behav       Date:  1987-05       Impact factor: 3.533

8.  Morphine antinociception in different strains of mice: relationship of supraspinal-spinal multiplicative interaction to tolerance.

Authors:  S C Roerig; J M Fujimoto
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

9.  Absence of cross-tolerance to heroin in morphine-tolerant mice.

Authors:  D G Lange; S C Roerig; J M Fujimoto; R I Wang
Journal:  Science       Date:  1980-04-04       Impact factor: 47.728

10.  Opioid agonists/antagonists in morphine-tolerant squirrel monkeys.

Authors:  L A Dykstra; M J Picker; K R Powell
Journal:  Pharmacol Biochem Behav       Date:  1990-07       Impact factor: 3.533

View more
  6 in total

1.  Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.

Authors:  M J Picker; J Yarbrough
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure.

Authors:  Ahmad A Altarifi; Kenner C Rice; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

3.  Morphine tolerance as a function of ratio schedule: response requirement or unit price?

Authors:  Christine E Hughes; Stacey C Sigmon; Raymond C Pitts; Linda A Dykstra
Journal:  J Exp Anal Behav       Date:  2005-05       Impact factor: 2.468

4.  Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.

Authors:  C A Paronis; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

5.  Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons.

Authors:  A J Mattox; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

6.  In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.

Authors:  Jennifer M Bossert; Eugene A Kiyatkin; Hannah Korah; Jennifer K Hoots; Anum Afzal; David Perekopskiy; Shruthi Thomas; Ida Fredriksson; Bruce E Blough; S Stevens Negus; David H Epstein; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2020-02-24       Impact factor: 13.382

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.